News Focus
News Focus
icon url

krenjp

04/07/08 1:30 PM

#265 RE: DewDiligence #264

Not sure what you mean.
icon url

rkrw

04/07/08 9:58 PM

#266 RE: DewDiligence #264

MRK puts out a long list of partnership wants and doesn't want and maturation inhibitors are listed as a want. FWIW.
icon url

krenjp

04/08/08 2:21 PM

#267 RE: DewDiligence #264

Dew, it would be appreciated if you substantiated your opinion with facts rather than coming up with what's on your mind only to create an impression. Feel free to post on the YMB if you cant substantiate them.
There is no reason for big pharma to neglect a new mechanism of action that can be coupled with NNRTIs, whether the first indication targets a portion of the markets does not preclude expanding the indication with the same or future drugs derived from it.

Regards.